ARTICLE | Clinical News
Asord becocalcidiol: Phase II started
January 21, 2008 8:00 AM UTC
CollaGenex began a U.S. Phase II trial to compare once-daily becocalcidiol to placebo and dovonex in 300 patients for 12 weeks. QuatRx granted CollaGenex exclusive rights outside of Japan for becocal...